After attracting GSK with its subcutaneous delivery tech at the top of the year, South Korea’s Alteogen has snared another ...

Over the last seven months, Boehringer Ingelheim has gained approvals and label expansions in the U.S. for two of its newest ...

Takeda is setting the stage for a sweeping new round of restructuring, aiming to streamline operations to bankroll upcoming ...

UCB will build a new manufacturing facility near its U.S. headquarters in Atlanta, Georgia. It will become the first major ...

The ‘90s sitcom “Full House” documented many of the ups and downs of growing up, including the often-excruciating experience ...

It’s time once again for Fierce Pharma Marketing’s annual #FierceMadness tournament. This time around, we're watching 64 ...

After gaining approval to treat multiple myeloma and generating sales of $120 million in its third full year on the market, ...

The warning letter homes in on a TV ad for Anktiva featuring ImmunityBio CEO Richard Adcock and Patrick Soon-Shiong, M.D., ...

Abivax has appointed Michael Nesrallah as its chief commercial officer, putting one of the people who turned Takeda’s Entyvio ...

India’s Strides Pharma has issued a voluntary recall for 89,592 bottles of children's ibuprofen oral suspension in the U.S.

Despite policy uncertainties in recent years, WuXi Biologics’ emphasis on its U.S. operations continued to pay off in 2025, ...

A high-profile drug fraud case that could see the pharmaceutical industry thrown into the Racketeer Influenced and Corrupt Organizations Act (RICO) legal realm has been allowed to advance with | The ...